Archer Investment Corp Age X Therapeutics, Inc. Transaction History

Archer Investment Corp

  • $373 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

May 19, 2020
SELL
$2.58 - $4.92 $258 - $492
-100 Closed
0 $0
Q4 2018

Apr 06, 2020
BUY
$2.49 - $5.5 $249 - $550
100 New
100 $0

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email